Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Development of an algorithm to discriminate between plasmid- and chromosomal-mediated AmpC β-lactamase production in Escherichia coli by elaborate phenotypic and genotypic characterization.

Coolen JPM, den Drijver EPM, Kluytmans JAJW, Verweij JJ, Lamberts BA, Soer JACJ, Verhulst C, Wertheim HFL, Kolwijck E.

J Antimicrob Chemother. 2019 Aug 25. pii: dkz362. doi: 10.1093/jac/dkz362. [Epub ahead of print]

PMID:
31504559
2.

Clinical cure rate and cost-effectiveness of carbapenem sparing beta-lactams versus meropenem for Gram-negative infections: a systematic review, meta-analysis, and cost-effectiveness analysis.

Nguyen CP, Dan Do TN, Bruggemann R, Oever JT, Kolwijck E, Adang EMM, Wertheim HF.

Int J Antimicrob Agents. 2019 Jul 5. pii: S0924-8579(19)30183-9. doi: 10.1016/j.ijantimicag.2019.07.003. [Epub ahead of print]

PMID:
31284041
3.

Management of infected pancreatic necrosis in the intensive care unit: a narrative review.

Wolbrink DRJ, Kolwijck E, Ten Oever J, Horvath KD, Bouwense SAW, Schouten JA.

Clin Microbiol Infect. 2019 Jun 22. pii: S1198-743X(19)30361-1. doi: 10.1016/j.cmi.2019.06.017. [Epub ahead of print] Review.

PMID:
31238118
4.

In Vitro Activity of Chlorhexidine Compared with Seven Antifungal Agents against 98 Fusarium Isolates Recovered from Fungal Keratitis Patients.

Oliveira Dos Santos C, Kolwijck E, van der Lee HA, Tehupeiory-Kooreman MC, Al-Hatmi AMS, Matayan E, Burton MJ, Eggink CA, Verweij PE.

Antimicrob Agents Chemother. 2019 Jul 25;63(8). pii: e02669-18. doi: 10.1128/AAC.02669-18. Print 2019 Aug.

5.

Quantification of viable bacterial load in artificial sputum spiked with Mycobacterium tuberculosis.

Friedrich SO, Kolwijck E, Karinja MN, van der Merwe L, Diacon AH.

Tuberculosis (Edinb). 2019 Mar;115:140-145. doi: 10.1016/j.tube.2019.03.001. Epub 2019 Mar 8.

PMID:
30948169
6.

Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study.

Kolwijck E, Seegers AEM, Tops SCM, van der Heijden AG, Sedelaar JPM, Ten Oever J.

BMC Infect Dis. 2019 Apr 3;19(1):303. doi: 10.1186/s12879-019-3932-4.

7.

Influenza virus and factors that are associated with ICU admission, pulmonary co-infections and ICU mortality.

Beumer MC, Koch RM, van Beuningen D, OudeLashof AM, van de Veerdonk FL, Kolwijck E, van der Hoeven JG, Bergmans DC, Hoedemaekers CWE.

J Crit Care. 2019 Apr;50:59-65. doi: 10.1016/j.jcrc.2018.11.013. Epub 2018 Nov 15.

PMID:
30481669
8.

Microbiological and immunological characteristics of a lethal pulmonary Aspergillus niger infection in a non-neutropenic patient.

Workum JD, de Jong SW, Gresnigt MS, Becker KL, Pickkers P, van de Veerdonk FL, Heijdra YF, Kolwijck E.

Med Mycol Case Rep. 2018 Mar 7;21:4-7. doi: 10.1016/j.mmcr.2018.03.002. eCollection 2018 Sep.

9.

Performance Validation of Selective Screening Agars for Guiding Antimicrobial Prophylaxis in Patients Undergoing Prostate Biopsy.

Tops SCM, Bruens M, van Mook-Vermulst S, Lamers-Jansen D, Engel T, van den Brink G, van Duuren R, Wertheim HFL, Kolwijck E.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00253-18. doi: 10.1128/JCM.00253-18. Print 2018 Sep.

10.

Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study.

van Lindert EJ, Bilsen MV, Flier MV, Kolwijck E, Delye H, Oever JT.

PLoS One. 2018 Jan 9;13(1):e0190249. doi: 10.1371/journal.pone.0190249. eCollection 2018.

11.

Biological evaluation of silver nanoparticles incorporated into chitosan-based membranes.

Shao J, Yu N, Kolwijck E, Wang B, Tan KW, Jansen JA, Walboomers XF, Yang F.

Nanomedicine (Lond). 2017 Nov;12(22):2771-2785. doi: 10.2217/nnm-2017-0172. Epub 2017 Oct 2.

PMID:
28967828
12.

Reduced rate of intensive care unit acquired gram-negative bacilli after removal of sinks and introduction of 'water-free' patient care.

Hopman J, Tostmann A, Wertheim H, Bos M, Kolwijck E, Akkermans R, Sturm P, Voss A, Pickkers P, Vd Hoeven H.

Antimicrob Resist Infect Control. 2017 Jun 10;6:59. doi: 10.1186/s13756-017-0213-0. eCollection 2017.

13.

Electrospun Nanofibrous Silk Fibroin Membranes Containing Gelatin Nanospheres for Controlled Delivery of Biomolecules.

Song J, Klymov A, Shao J, Zhang Y, Ji W, Kolwijck E, Jansen JA, Leeuwenburgh SCG, Yang F.

Adv Healthc Mater. 2017 Jul;6(14). doi: 10.1002/adhm.201700014. Epub 2017 May 2.

PMID:
28464454
14.

Animal models for percutaneous-device-related infections: a review.

Shao J, Kolwijck E, Jansen JA, Yang F, Walboomers XF.

Int J Antimicrob Agents. 2017 Jun;49(6):659-667. doi: 10.1016/j.ijantimicag.2017.01.022. Epub 2017 Apr 6. Review.

PMID:
28392441
15.

Influenza-Associated Aspergillosis in Critically Ill Patients.

van de Veerdonk FL, Kolwijck E, Lestrade PP, Hodiamont CJ, Rijnders BJ, van Paassen J, Haas PJ, Oliveira Dos Santos C, Kampinga GA, Bergmans DC, van Dijk K, de Haan AF, van Dissel J, van der Hoeven HG, Verweij PE; Dutch Mycoses Study Group.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):524-527. doi: 10.1164/rccm.201612-2540LE. Epub 2017 Apr 7. No abstract available.

PMID:
28387526
16.

Electrophoretic Deposition of Chitosan Coatings Modified with Gelatin Nanospheres To Tune the Release of Antibiotics.

Song J, Chen Q, Zhang Y, Diba M, Kolwijck E, Shao J, Jansen JA, Yang F, Boccaccini AR, Leeuwenburgh SC.

ACS Appl Mater Interfaces. 2016 Jun 8;8(22):13785-92. doi: 10.1021/acsami.6b03454. Epub 2016 May 23.

PMID:
27167424
17.

Voriconazole-Susceptible and Voriconazole-Resistant Aspergillus fumigatus Coinfection.

Kolwijck E, van der Hoeven H, de Sévaux RG, ten Oever J, Rijstenberg LL, van der Lee HA, Zoll J, Melchers WJ, Verweij PE.

Am J Respir Crit Care Med. 2016 Apr 15;193(8):927-9. doi: 10.1164/rccm.201510-2104LE. No abstract available.

PMID:
27082535
18.

Antibacterial effects of electrospun chitosan/poly(ethylene oxide) nanofibrous membranes loaded with chlorhexidine and silver.

Song J, Remmers SJ, Shao J, Kolwijck E, Walboomers XF, Jansen JA, Leeuwenburgh SC, Yang F.

Nanomedicine. 2016 Jul;12(5):1357-64. doi: 10.1016/j.nano.2016.02.005. Epub 2016 Mar 10.

PMID:
26970025
19.

[Invasive pulmonary aspergillosis in influenza].

Kolwijck E, Scheper H, Beuving J, Kuijper EJ, van der Hoeven JG, Verweij PE.

Ned Tijdschr Geneeskd. 2015;159:A7431. Dutch.

PMID:
25714763
20.

The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease.

Kolwijck E, van de Veerdonk FL.

Eur J Immunol. 2014 Nov;44(11):3156-65. doi: 10.1002/eji.201344404. Epub 2014 Oct 27. Review.

21.

Early stationary phase culture supernatant accelerates growth of sputum cultures collected after initiation of anti-tuberculosis treatment.

Kolwijck E, Friedrich SO, Karinja MN, van Ingen J, Warren RM, Diacon AH.

Clin Microbiol Infect. 2014 Jul;20(7):O418-20. doi: 10.1111/1469-0691.12441. Epub 2013 Nov 29.

22.

Short-term storage does not affect the quantitative yield of Mycobacterium tuberculosis in sputum in early-bactericidal-activity studies.

Kolwijck E, Mitchell M, Venter A, Friedrich SO, Dawson R, Diacon AH.

J Clin Microbiol. 2013 Apr;51(4):1094-8. doi: 10.1128/JCM.02751-12. Epub 2013 Jan 23.

23.

Leptospirosis in a Dutch catfish farm.

Kolwijck E, Dofferhoff AS, van de Leur J, Meis JF.

Neth J Med. 2011 Apr;69(4):201-4.

24.

CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.

van Altena AM, Kolwijck E, Spanjer MJ, Hendriks JC, Massuger LF, de Hullu JA.

Gynecol Oncol. 2010 Nov;119(2):265-9. doi: 10.1016/j.ygyno.2010.07.025. Epub 2010 Aug 24.

PMID:
20797777
25.

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer.

Kolwijck E, Kos J, Obermajer N, Span PN, Thomas CM, Massuger LF, Sweep FC.

Eur J Clin Invest. 2010 Jul;40(7):591-9. doi: 10.1111/j.1365-2362.2010.02305.x. Epub 2010 May 12.

PMID:
20482593
26.

Ovarian cyst fluid of serous ovarian tumors contains large quantities of the brain amino acid N-acetylaspartate.

Kolwijck E, Wevers RA, Engelke UF, Woudenberg J, Bulten J, Blom HJ, Massuger LF.

PLoS One. 2010 Apr 22;5(4):e10293. doi: 10.1371/journal.pone.0010293.

27.

Prevalence of cysts in epithelial ovarian cancer.

Kolwijck E, Lybol C, Bulten J, Vollebergh JH, Wevers RA, Massuger LF.

Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):96-100. doi: 10.1016/j.ejogrb.2010.02.044. Epub 2010 Mar 29.

PMID:
20303211
28.

Prognostic value of CA 125 in ovarian cyst fluid of patients with epithelial ovarian cancer.

Kolwijck E, Span PN, Thomas CM, Bulten J, Sweep FC, Massuger LF.

Oncol Rep. 2010 Feb;23(2):579-84.

PMID:
20043124
29.

Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature.

Kolwijck E, Thomas CM, Bulten J, Massuger LF.

Int J Gynecol Cancer. 2009 Nov;19(8):1335-8. doi: 10.1111/IGC.0b013e3181a83e04.

PMID:
20009886
30.

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumors.

Kolwijck E, Massuger LF, Thomas CM, Span PN, Krasovec M, Kos J, Sweep FC.

J Cancer Res Clin Oncol. 2010 May;136(5):771-8. doi: 10.1007/s00432-009-0716-z. Epub 2009 Nov 14.

31.

GSTP1-1 in ovarian cyst fluid and disease outcome of patients with ovarian cancer.

Kolwijck E, Zusterzeel PL, Roelofs HM, Hendriks JC, Peters WH, Massuger LF.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2176-81. doi: 10.1158/1055-9965.EPI-09-0098.

32.

N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.

Kolwijck E, Engelke UF, van der Graaf M, Heerschap A, Blom HJ, Hadfoune M, Buurman WA, Massuger LF, Wevers RA.

NMR Biomed. 2009 Dec;22(10):1093-9. doi: 10.1002/nbm.1417.

PMID:
19593761
33.

Sister Mary Joseph nodule as a first and only sign of extraovarian carcinoma: a case report and review of the literature.

Kolwijck E, Kruitwagen RF, Massuger LF.

Arch Pathol Lab Med. 2008 Dec;132(12):1943-5. doi: 10.1043/1543-2165-132.12.1943. Review.

PMID:
19061296
34.

A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis.

van Altena AM, Wijnberg GJ, Kolwijck E, de Hullu JA, Massuger LF.

Gynecol Oncol. 2008 Feb;108(2):445-8. Epub 2007 Nov 26.

PMID:
18029289
35.

Supplemental Content

Loading ...
Support Center